Breaking News - The Fly

Open Search

KNTE

Kinnate Biopharma

$

()

Xoma announces closing of tender offer

XOMA , KNTE

4/3/2024 - 09:14am

Kinnate Biopharma sells exarafenib to Pierre Fabre Laboratories

KNTE

3/1/2024 - 08:37am

Kinnate Biopharma sells exarafenib to Pierre Fabre Laboratories

KNTE

3/1/2024 - 08:34am

Kinnate Biopharma price target raised by $1.09 at Stifel, here's why

KNTE , XOMA

2/26/2024 - 07:40am

Kinnate Biopharma just downgraded at William Blair, here's why

KNTE

2/16/2024 - 12:51pm

Xoma acquisition boosts royalty growth potential, says H.C. Wainwright

XOMA , KNTE

2/16/2024 - 11:25am

Xoma to acquire Kinnate for between $2.3352-$2.5879 per share plus CVR

KNTE , XOMA

2/16/2024 - 08:05am

Xoma to acquire Kinnate Biopharma for between $2.3352-$2.5879 per share plus CVR

XOMA , KNTE

2/16/2024 - 08:03am

Pyxis Oncology announces appointment of Kobayashi as CMO

PYXS , KNTE

11/28/2023 - 07:02am

Kinnate Biopharma reports Q3 EPS (65c), consensus (67c)

KNTE

11/9/2023 - 16:42pm

Dell upgraded, Starbucks downgraded: Wall Street's top analyst calls

RCL , CCL , CVS

…

9/19/2023 - 10:00am

Fly Intel: Pre-market Movers

CVS , AVGR , APOG

…

9/19/2023 - 09:04am

Kinnate Biopharma price target lowered to $2 from $31 at Jefferies

KNTE

9/19/2023 - 07:57am

Kinnate Biopharma downgraded to Neutral from Outperform at Wedbush

KNTE

9/19/2023 - 06:38am

Kinnate Biopharma downgraded to Neutral from Buy at H.C. Wainwright

KNTE

9/19/2023 - 06:09am